Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
114.45
+0.11 (0.10%)
Mar 9, 2026, 1:13 PM EDT - Market open
Arcellx Market Cap
Arcellx has a market cap or net worth of $6.69 billion as of March 9, 2026. Its market cap has increased by 88.64% in one year.
Market Cap
6.69B
Enterprise Value
6.22B
1-Year Change
88.64%
Ranking
Category
Stock Price
$114.45
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $6.69B, an increase of 1,230.16%. That is a compound annual growth rate of 88.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.69B | 77.34% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.95B |
| Nuvalent | 7.82B |
| Cytokinetics | 7.44B |
| Krystal Biotech | 7.42B |
| Belite Bio | 6.82B |
| Kymera Therapeutics | 6.82B |
| Rhythm Pharmaceuticals | 6.39B |
| Cogent Biosciences | 5.97B |